FDA approves trimetrexate as second-line therapy for Pneumocystis carinii pneumonia.

Authors
Journal	American journal of hospital pharmacy (Am J Hosp Pharm) Vol. 51 Issue 5 Pg. 591-2 (Mar 01 1994) ISSN: 0002-9289 [Print] United States
PMID	8203380 (Publication Type: News)
Chemical References	Trimetrexate
Topics	Humans Pneumonia, Pneumocystis (drug therapy) Trimetrexate (therapeutic use) United States United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!